| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.44▼ | 1.45▼ | 1.45▼ | 1.44▼ | 1.44▼ |
| MA10 | 1.45▼ | 1.45▼ | 1.45▼ | 1.44▼ | 1.52▼ |
| MA20 | 1.45▼ | 1.45▼ | 1.45▼ | 1.43▲ | 1.50▼ |
| MA50 | 1.45▼ | 1.44▼ | 1.43▲ | 1.52▼ | 1.40▲ |
| MA100 | 1.45▼ | 1.43▲ | 1.43▲ | 1.47▼ | 1.45▼ |
| MA200 | 1.44▲ | 1.46▼ | 1.50▼ | 1.39▲ | 1.64▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.001▼ | -0.001▼ | 0.007▲ | -0.011▼ |
| RSI | 43.947▼ | 46.016▼ | 48.665▼ | 47.284▼ | 49.107▼ |
| STOCH | 27.778 | 33.333 | 39.167 | 61.111 | 32.482 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -40.000 | -54.688 |
| CCI | -103.704▼ | -186.667▼ | -111.111▼ | 62.641 | -29.084 |
|
Tuesday, September 09, 2025 07:04 PM
NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage company developing broad-spectrum antiviral drugs designed to resist viral escape, annou ...
|
|
Tuesday, September 09, 2025 04:53 AM
NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
|
|
Monday, September 08, 2025 06:28 AM
Hi, and welcome to the next edition of our CEO Chat. I am David Bautz, Senior Biotechnology Analyst with Zacks Small Cap Research . Joining me today is Dr. Anil Diwan. He's the CEO of NanoViricides, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 1.445 | 1.465 | 1.44 | 1.44 | 166,614 |
| 16/09/25 | 1.45 | 1.45 | 1.43 | 1.45 | 39,199 |
| 15/09/25 | 1.45 | 1.468 | 1.4201 | 1.45 | 151,835 |
| 12/09/25 | 1.42 | 1.46 | 1.41 | 1.45 | 85,200 |
| 11/09/25 | 1.4191 | 1.445 | 1.4191 | 1.43 | 96,938 |
| 10/09/25 | 1.45 | 1.47 | 1.43 | 1.43 | 94,600 |
| 09/09/25 | 1.47 | 1.48 | 1.42 | 1.46 | 199,530 |
| 08/09/25 | 1.49 | 1.49 | 1.44 | 1.44 | 59,807 |
| 05/09/25 | 1.37 | 1.50 | 1.35 | 1.49 | 253,900 |
| 04/09/25 | 1.40 | 1.43 | 1.37 | 1.38 | 62,400 |
|
|
||||
|
|
||||
|
|